Role for NOD2 in Mycobacterium tuberculosis‐induced iNOS expression and NO production in human macrophages

M.tb, which causes TB, is a host‐adapted intracellular pathogen of macrophages. Macrophage intracellular PRRs, such as NOD proteins, regulate proinflammatory cytokine production in response to various pathogenic organisms. We demonstrated previously that NOD2 plays an important role in controlling the inflammatory response and viability of M.tb and Mycobacterium bovis BCG in human macrophages. Various inflammatory mediators, such as cytokines, ROS, and RNS, such as NO, can mediate this control. iNOS (or NOS2) is a key enzyme for NO production and M.tb control during infection of mouse macrophages; however, the role of NO during infection of human macrophages remains unclear, in part, as a result of the low amounts of NO produced in these cells. Here, we tested the hypothesis that activation of NOD2 by its ligands (MDP and GMDP, the latter from M.tb) plays an important role in the expression and activity of iNOS and NO production in human macrophages. We demonstrate that M.tb or M. bovis BCG infection enhances iNOS expression in human macrophages. The M.tb‐induced iNOS expression and NO production are dependent on NOD2 expression during M.tb infection. Finally, NF‐κB activation is required for NOD2‐dependent expression of iNOS in human macrophages. Our data provide evidence for a new molecular pathway that links activation of NOD2, an important intracellular PRR, and iNOS expression and activity during M.tb infection of human macrophages.

[1]  N. Suttorp,et al.  NOD-Like Receptors in Lung Diseases , 2013, Front. Immunol..

[2]  L. Schlesinger,et al.  Mini Review Article , 2022 .

[3]  Murugesan V. S. Rajaram,et al.  NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages , 2011, Cellular microbiology.

[4]  K. N. Balaji,et al.  Intracellular Pathogen Sensor NOD2 Programs Macrophages to Trigger Notch1 Activation* , 2010, The Journal of Biological Chemistry.

[5]  J. Achkar,et al.  ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. , 2010, Gastroenterology.

[6]  Murugesan V. S. Rajaram,et al.  Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune Responses , 2010, The Journal of Immunology.

[7]  J. Pittet,et al.  Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: role of Hsp90 and Hsp70 , 2010, Thorax.

[8]  M. Reed,et al.  Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide , 2009, The Journal of experimental medicine.

[9]  P. Tripathi Nitric oxide and immune response. , 2007, Indian journal of biochemistry & biophysics.

[10]  S. Gandotra,et al.  Nucleotide-Binding Oligomerization Domain Protein 2-Deficient Mice Control Infection with Mycobacterium tuberculosis , 2007, Infection and Immunity.

[11]  Kyung Soo Park,et al.  Identification of a classic cytokine‐induced enhancer upstream in the human iNOS promoter , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Murugesan V. S. Rajaram,et al.  Akt/Protein Kinase B Modulates Macrophage Inflammatory Response to Francisella Infection and Confers a Survival Advantage in Mice1 , 2006, The Journal of Immunology.

[13]  D. Maskell,et al.  IFN-γ Enhances Production of Nitric Oxide from Macrophages via a Mechanism That Depends on Nucleotide Oligomerization Domain-2 , 2006, The Journal of Immunology.

[14]  J. Gunn,et al.  Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Braun,et al.  DAF-FM (4-Amino-5-methylamino-2′,7′-difluorofluorescein) Diacetate Detects Impairment of Agonist-Stimulated Nitric Oxide Synthesis by Elevated Glucose in Human Vascular Endothelial Cells: Reversal by Vitamin C and l-Sepiapterin , 2005, Journal of Pharmacology and Experimental Therapeutics.

[16]  E. Moilanen,et al.  Nitric oxide production and signaling in inflammation. , 2005, Current drug targets. Inflammation and allergy.

[17]  John Bertin,et al.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.

[18]  C. Lowenstein,et al.  iNOS (NOS2) at a glance , 2004, Journal of Cell Science.

[19]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[20]  D. Voelker,et al.  Pulmonary Surfactant Protein A Up-Regulates Activity of the Mannose Receptor, a Pattern Recognition Receptor Expressed on Human Macrophages1 , 2002, The Journal of Immunology.

[21]  E. Chan,et al.  Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. , 2002, American journal of respiratory and critical care medicine.

[22]  G. Schuler,et al.  Induction of iNOS expression in skeletal muscle by IL-1β and NFκB activation: an in vitro and in vivo study , 2002 .

[23]  E. Chan,et al.  What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge. , 2001, American journal of respiratory cell and molecular biology.

[24]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[25]  Patrick Griffin,et al.  Peroxynitrite reductase activity of bacterial peroxiredoxins , 2000, Nature.

[26]  C. Nathan,et al.  Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Horng-Chyuan Lin,et al.  Nitric Oxide Modulates Interleukin-1 β and Tumor Necrosis Factor- α Synthesis by Alveolar Macrophages in Pulmonary Tuberculosis , 2000 .

[28]  B. Bloom,et al.  Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  R. Hunter,et al.  Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. , 1998, Nitric oxide : biology and chemistry.

[30]  C. Nathan,et al.  A Novel Antioxidant Gene from Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.

[31]  S. Ichiyama,et al.  Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages , 1997, Infection and immunity.

[32]  J. Mudgett,et al.  Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Ishii,et al.  Increased Nitric Oxide Production and Inducible Nitric Oxide Synthase Activity in Colonic Mucosa of Patients with Active Ulcerative Colitis and Crohn's Disease , 1997, Digestive Diseases and Sciences.

[34]  I. Orme,et al.  Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates , 1997, Infection and immunity.

[35]  N. Boéchat,et al.  Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis , 1996, The Journal of experimental medicine.

[36]  A. Nussler,et al.  A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. , 1995, Journal of immunology.

[37]  J. Weinberg,et al.  Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. , 1995, Blood.

[38]  K. Tanaka,et al.  Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[39]  L. Wu,et al.  Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. , 1994, The Journal of clinical investigation.

[40]  C. Lowenstein,et al.  Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. , 1994, The Journal of biological chemistry.

[41]  M. Grisham,et al.  Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. , 1994, The Journal of pharmacology and experimental therapeutics.

[42]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[43]  M. Currie,et al.  A fluorometric assay for the measurement of nitrite in biological samples. , 1993, Analytical biochemistry.

[44]  S. Milstien,et al.  Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages. , 1993, Biochemical and biophysical research communications.

[45]  Tamaki Yamada,et al.  Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats. , 1992, Gastroenterology.

[46]  M. Horwitz,et al.  Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. , 1991, Journal of immunology.

[47]  W. Kozumbo,et al.  Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. , 1990, The American review of respiratory disease.

[48]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[49]  D. Jewell,et al.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.

[50]  D. Philpott,et al.  Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.

[51]  M. J. Cody,et al.  TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. , 2002, Nature immunology.

[52]  G. Schuler,et al.  Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study. , 2002, Cardiovascular research.

[53]  H. Kuo,et al.  Nitric oxide modulates interleukin-1beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pulmonary tuberculosis. , 2000, American journal of respiratory and critical care medicine.

[54]  S. Kawachi,et al.  Role of nitric oxide in the regulation of acute and chronic inflammation. , 2000, Antioxidants & redox signaling.

[55]  B. Hamilton,et al.  Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[56]  D. Wink,et al.  Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. , 1996, Methods in enzymology.